BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

St. Jude Medical (STJ) Invests $40 Million in Spinal Modulation; Gains Option to Acquire Company


6/7/2013 10:01:30 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

St. Jude Medical Inc. (STJ) has agreed to invest $40 million in a privately held medical device company that developed a new pain management therapy, gaining the right to exclusively distribute the system and potentially acquire the company. The Menlo Park, Calif.-based Spinal Modulation Inc. has developed a type of neuromodulation therapy that provides a new pain management option for patients with chronic, intractable pain. The Axium Neurostimulator System works through stimulation of the dorsal root ganglion, which are small structures that contain nerve fibers, which carry signals to the brain. The agreement gives St. Jude an exclusive option to distribute the Axium system in international markets where it is approved for sale. St. Jude Medical will also have the exclusive option to acquire the company for up to $300 million plus certain revenue-based milestones following U.S. commercialization of the system.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->